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Abstract 
Delivery of nanoparticles to breast tumors involves a coupled analysis of the fluid and solute 
transport mechanisms in the microvasculature, across the vessel walls, and in the extravascular 
spaces. Tumor numerical models have been used to quantify solute transport with a single capillary 
embedded in an infinite tumor expanse, but measurements from different mammalian tumors 
suggest that a tissue containing a single capillary with an infinite intercapillary distance assumption 
is not physiological. The present study aims to investigate the limits of the intercapillary distance 
within which nanoparticle transport resembles solute extravasation in a breast tumor model as a 
function of the solute size, the intercapillary separation, and the flow direction in microvessels.  
Dextran transport properties obtained from an in vitro tumor platform containing a single vessel 
provided validation of the numerical model. Solute transport is modeled using mixture theory, 
applied to the nanoparticle accumulation and concentration decay in the tissue space for different 
vascular configurations. A comparison of a single capillary configuration (SBC) with two parallel 
cylindrical blood vessels (2 BC) and a lymph vessel parallel to a blood vessel (BC_LC) embedded 
in the tissue cylinder is performed for five solute molecular weights between 0.1 kDa and 70 kDa. 
The effects of counter flow (CN) versus co-current flow (CO) on the solute accumulation were 
also investigated and the scaling of solute accumulation-decay time and concentration was 
explored.  
We found that the presence of a second capillary reduces the extravascular concentration compared 
to a single capillary and this reduction is enhanced by the presence of a lymph vessel.  Co-current 
flow direction between two adjacent vessels led to nonhomogeneous nanoparticle distribution for 
larger particle sizes in the tissue space, while smaller particles (0.1 kDa and 3 kDa) showed the 
propensity to get trapped locally in the tissue during counter-current flow. Varying the 
intercapillary distance with respect to vessel diameter shows a deviation of 10-30 % concentration 
for 2 BC and 45-60% concentration for BC_LC configuration compared to the reference SBC 
configuration.  
Finally, we introduce a non-dimensional time scale that captures the concertation as a function of 
the transport and geometric parameters. We find that the peak solute concentration in the tissue 
space occurs at a non-dimensional time, 𝑇𝑝𝑒𝑎𝑘
∗   = 0.027 ± 0.018, irrespective of the solute size, 
tissue architecture, and microvessel flow direction.  This suggests that if indeed such a universal 
time scale holds, the knowledge of this time would allow estimation of the time window at which 
solute concentration in tissue peaks. Hence this can aid in the design of future therapeutic efficacy 
studies as an example for triggering drug release or laser excitation in the case of photothermal 
therapies. 
 
Keywords – Solute transport, cancer tissue, mixture theory modeling  
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Introduction 
The total cost of cancer care in the United States is projected to increase by 39% from 2010 to 
2020 (1). Primary areas of cancer research involve improving the efficacy of chemotherapeutic 
agents at the tumor sites and minimizing their toxic side effects in the non-target sites (2-4). 
Conventional chemotherapeutic agents (5) are non-specifically distributed in the body which limits 
the effectiveness of the drug dose and increases toxicity in normal cells. Drug carriers with 
hydrodynamic diameter 3-200 nm accumulate preferentially in tumors owing to the enhanced 
permeability and retention (EPR) effect (6) exploiting the wider pores in tumor vessels and the 
impaired lymphatic drainage in diseased tissues. The transport mechanism of these nanoparticles 
in tumors is a function of the hemodynamics, nanoparticle transport parameters (solute 
permeability, solute diffusivity, reflection coefficient) as well as the extravascular matrix 
properties (porosity, hydraulic conductivity). Before the binding/uptake by the cancer cell these 
particles overcome three major transport barriers: transport through microvasculature, 
translocation across the endothelial wall, and diffusion within the extracellular tissue matrix. Using 
a numerical model to investigate the nanoparticle transport mechanics could enable determination 
of the exact time interval between nanoparticle introduction and drug release to achieve desired 
therapeutic efficacy based on patient specific tumor measurements.  
The majority of the existing multiscale models use the Darcy’s law, Starling’s law, and Poiseuille’s 
law to analyze extravascular, trans-capillary, and intravascular transport respectively (7-12). 
Poiseuille’s law cannot account for variations in capillary diameter and the inhomogeneous nature 
of blood. Deviations from Starling’s law are expected when osmotic terms would include other 
endogenous solutes in addition to proteins. Darcy’s law does not include the dependence of 
interstitial flow on local fluid chemical potential. Schuff et al. (13, 14) used mixture theory 
equations in an axisymmetric tissue geometry containing a concentric blood vessel and showed 
the dependence of extravascular fluid transport on chemical gradients in addition to hydrostatic 
pressure which was previously suggested (15, 16) and observed (17) but not commonly accounted 
for in previous transport models. In the present work, the mixture theory model is implemented in 
dual- tissue geometries to predict nanoparticle distribution in cancerous breast tissues over a wide 
range of particle sizes (0.5-15 nm) and molecular weights (0.1-70 kDa).  
We hypothesize that nanoparticle distribution in breast tumors is a function of solute size, 
intercapillary separation, and flow direction and there exists a characteristic non-dimensional time, 
𝑇𝑝𝑒𝑎𝑘
∗ , for which solute concentration in the tissue space is maximum. We test this hypothesis by 
investigating the transport mechanisms of five solute types (0.1, 3, 10, 40 and 70 kDa) in tumor 
systems containing a single vessel (SBC) and compare with tumors possessing dual-vessel (blood 
capillaries only (2 BC), blood capillary and a lymph capillary (BC_LC)) tissue systems with 
varying intercapillary separation. The mixture theory equations are used for the first time and their 
predictive capability validated with measurements of dextran transport in an in vitro tumor 
platform containing multiple blood vessels  
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Materials and Methods  
The mixture theory equations model the transport (13, 14) of the fluid and solute in three distinct 
regions of a representative vascularized tumor geometry: a) in the intravascular space which 
consists of the plasma layer concentric with an inner core of red blood cells, b) across the capillary 
wall which is thin and semi-permeable and c) the extravascular space that comprises of the 
interstitial fluids and solutes flowing through a fibrous matrix.  A finite element software package 
COMSOL 4.2 (COMSOL, Burlington, MA) was used to run the simulations. A schematic of the 
vascularized breast tumor configuration along with the transport pathways is shown in Figure 1. 
The blood vessel in Figure 1 allows both intravasation and extravasation depicted by blue and red 
arrows respectively. The lymph vessel allows intravasation (blue arrow) only and drains the 
lymphatic fluid out of the tissue. 
 
Figure 1 : Schematic of a tissue containing blood capillary and lymph vessel. The arrows 
show the main transport mechanisms of a solute in the tissue. The extravascular space 
contains interstitial fluid flowing through a fibrous matrix. The blood vessel contains an 
inner core of red blood cells (RBC) surrounded by an outer plasma layer. The lymph vessel 
contains the interstitial fluid in it. No extravasation occurs in lymph vessels. 
Mixture Theory Model Parameters 
The mixture theory model requires fifteen input parameters that account for the mechanical 
properties of the porous matrix, type of the injected solute, and vascular geometry. For the current 
study, these parameters correspond to a human breast tumor and are presented in Table 1. The 
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governing equations and boundary conditions for the mixture theory model have been derived in 
(13).  A sensitivity analysis of the input parameters, calibration and subsequent validation of the 
model was carried out by Schuff et al. in (14). All the equations used in the simulations are 
explained in the Appendix A. 
Table 1: Input parameters for mixture theory model. Values are for different types of cancer 
tissues adopted from the literature. References are listed in the last column of the table. 
Solute Dependent Parameters 
Solute Molecular 
Weight (kDa), MW 
0.1 3.0 10.0 40.0 70.0  
Hydrodynamic 
Diameter (nm) 
0.69 1.6 5.46 13.2 14.4 (18-20) 
Reflection coefficient, 
𝝈 
0.00025 0.00025 0.02500 0.08600 0.14000 (13, 14, 
21, 22) 
Solute Permeability 
coefficient , Pd 
(x10-8 m/s) 
800 174 70 33 30 (13, 14, 
23-25) 
Diffusion Coefficient 
(x10-11 m2/s), Df 
89.6 17.0 9.6 7.8 3.6 (26-29) 
Retardation factor, RF 1.10 1.10 1.07 0.94 0.84 (27-31) 
Initial solute 
concentration 
(mol/m3), Co 
6.11 0.20 0.08 0.02 0.01 (26) 
Flow Parameters 
Pressure gradient along blood vessel 
(Pa), dP 
2394 (32-35) 
Hydrostatic pressure in arteriole 
(Pa), Par 
4394 (32-35) 
Boundary tissue pressure (Pa), Po 2700 (36-39) 
Osmotic Pressure gradient (Pa) 2500 (13, 14, 18, 32) 
Hydraulic conductivity (x10-15) 
(m2/Pa-s) 
400 (13, 14, 37, 40) 
Hydraulic permeability (x10-10) 
(m/Pa-s) 
10 (13, 14, 37) 
Tissue porosity, ∅ 0.4 (37, 41-43) 
Geometrical Parameters 
Length of microvessels (mm), l 1 (44, 45) 
Diameter of microvessels (μm), d 10 (44, 46, 47) 
Diameter of tissue (μm), D 200 (44, 46, 48-50) 
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Experimental Validation of Mixture Theory Model 
The accuracy of the computational model was confirmed with experimental measurements 
performed in a physiologically representative 3D vascularized in vitro tumor microenvironment. 
Essential model parameters such as tissue porosity, vessel porosity, solute permeability, and solute 
diffusivity were measured using the in vitro platform and implemented in the model (Table 2). 
The concentration-time histories were obtained from the mixture theory equations using the 
minimum, maximum, and mean values of the tissue parameters measured from in vitro platform. 
The simulation results were also compared with experimental measurements of from dextran 
transport in the same vascularized  in vitro platform (Figure 2). Details explaining the fabrication 
and measurement processes can be found in the appendix B. 
Experimental and numerical comparison of concentration-time histories 
Numerical simulations for the model validation studies were separately processed with identical 
tissue properties and boundary conditions as obtained from the experiment. The intensity-time 
histories were spatially averaged at a radial location of 600 𝜇m. These were normalized by the 
maximum intensity inside the vessel at that time instant. For each of 3kDa and 70kDa solutes, 
transport was studied in N=3 tissue samples with identical fabrication parameters. The normalized 
intensity profile of dextran particles from these experiments corresponds to the normalized 
concentration from the numerical simulations (Figure 2). The error bars correspond to the 
experimental variability observed across 3 samples at each time instant. For 3kDa, the smaller 
solute, the experimental data till 1 hr matches well with the simulation curve from maximum values 
of input parameters. The deviation of experimental results from mean simulated values decreases 
with increasing time from 1hr to 2 hrs. The experimental data for the 70 kDa solute almost coincide 
with the mean simulation curve and is closely enveloped by the maximum and minimum 
simulation curves. To our knowledge, this is the first in vitro model that measured different 
porosity values in the extravascular and intravascular spaces. 
Table 2 : Parameters from the fabricated tissue platform used in the equivalent simulation 
Parameters from fabricated 
tissue platform 
Mean Min Max 
Vessel diameter (𝝁m) 715 - - 
Tissue diameter (𝝁m) 3000 - - 
Tissue Porosity 0.53 0.49 0.59 
Vascular Porosity 0.4 0.37 0.43 
Solute Diffusivity (𝒎𝟐/s) 3 kDa: 25e-11 
70 kDa: 4.3e-11 
3 kDa: 20e-11 
70 kDa: 3.7e-
11 
3 kDa: 30e-11 
70 kDa: 4.9e-
11 
Solute Permeability (m/s) 3 kDa: 32e-8 
70 kDa: 9e-8 
3 kDa: 24e-8 
70 kDa: 7e-8 
3 kDa: 43e-8 
70 kDa: 11e-8 
Hydraulic Permeability (𝒎𝟐) 1e-12 - - 
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Figure 2 : Comparison of experimental and numerical normalized concentration-time 
histories for 3kDa and 70 kDa solutes in a single capillary cancer tissue. a) The numerical 
curve under predicts the mean experimental concentration in earlier times and 
overpredicts in later times. b) The percentage deviation of the simulation concentration 
from the mean experimental concentration. For 70kDa the deviation is least at 1 hour while 
for 3kDa it is least at 2 hours. 
Vascular Tissue Configurations and Test Matrix 
In the current study three geometrical configurations of the vessels in the tissue are considered: 
the single blood capillary (SBC) configuration, the double blood capillary (2 BC) configuration, 
the blood capillary and the lymph vessel (BC_LC) configuration. These are shown in Figure 3 
along with the transport pathways. The tasks were split into 3 tests listed in Table 3. The flow 
direction is same (CO) in parallel microvessels for tests 1 and 3. The intercapillary distance (L) in 
the dual-microchannel configurations is 100 𝜇m in tests 1 and 2 (27, 46, 50). The choice of flow 
parameters, tissue matrix properties and solute dependent parameters in each test are depicted in 
Table 1. 
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Table 3 : Test matrix developed for conducting the study 
Configuration Flow Direction Type Intercapillary 
separation (𝝁𝒎) 
Solute Molecular weight 
(kDa) 
Test 1 : Effect of solute size 
SBC N/A N/A 0.1, 3.0, 10.0, 40.0, 70.0 
2 BC CO 100 0.1, 3.0, 10.0, 40.0, 70.0 
 BC_LC CO 100 0.1, 3.0, 10.0, 40.0, 70.0 
Test 2 : Effect of flow direction in microvessels  
2 BC CO 100 0.1, 3.0, 10.0, 40.0, 70.0 
2 BC CN 100 0.1, 3.0, 10.0, 40.0, 70.0 
BC_LC CO 100 0.1, 3.0, 10.0, 40.0, 70.0 
BC_LC CN 100 0.1, 3.0, 10.0, 40.0, 70.0 
Test 3 : Effect of intercapillary separation 
SBC N/A N/A 3.0, 10.0 
2 BC CO 10,50,100,250,1250 3.0, 10.0 
BC_LC CO 10,50,100,250,1250 3.0, 10.0 
 
 
 
 
Figure 3 : Three schematic tissue configurations with transport pathways that have been 
numerically modelled. A) single capillary embedded in tissue cylinder B) parallel flow blood 
capillaries in tissue cylinder C) lymph vessel parallel to blood vessel enclosed in tissue 
cylinder. d is the capillary diameter, L is the intercapillary separation and D is tissue 
diameter. 
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Table 4: Intercapillary distance from invivo tissues with capillary diameer, d=10 𝝁𝒎 
Tissue Type Intercapillary 
Separation (L, 
𝝁𝒎) 
L/d References 
Rat mammary 
tumors 
50 5 (44) 
Rabbit neoplastic 
tissue 
101 10.1 (48) 
Mammary 
carcinoma 
80-135 8-13.5 (49),(51),(50),(46) 
Normal breast 
tissue 
215 21.5 (51) 
Human large 
intestine 
107 10.7 (52) 
Human colorectal 
tumor periphery 
54 5.4 (53) 
Human colorectal 
tumor center 
177 17.7 (53) 
 
Test 1: Effect of solute size on transport 
Five solutes (0.1 kDa, 3 kDa, 10 kDa, 40 kDa, 70 kDa) are injected at the inlet of the blood 
capillaries in each configuration to delineate the effect of solute size on transport. The geometry, 
hydraulic parameters and transport properties of the solute molecules in a breast tumor are in 
Table 1. The transport properties of 0.1 kDa solute are estimated from the calibration model 
developed in (14). 
Test 2: Effect of flow direction in capillaries on transport 
The second test investigates the influence of co-current flow and counter-current flow in both 
2BC and BC_LC tissue configurations and compares the solute transport mechanisms with the 
SBC configuration.  
Test 3: Effect of intercapillary separation on transport 
In the third test, the capillary separation (L) is varied with respect to blood capillary diameter (d), 
(L/d=1, 5, 10, 25, 125), to test the solute accumulation in the tissue space as compared to the SBC 
configuration. Due to longer computational time, this test is run for two solutes, 3kDa 
(representative of a therapeutic drug) and 10 kDa (representative of the size of drug carrying 
nanoparticle). The intercapillary separation, L, is defined as the shortest distance measured 
between all non-adjacent capillary pairs in a loop (44). The tissue diameter (D) is twice the 
separation value (D=2L) to maintain the same volume of tissue around each microvessel with 
respect to the SBC configuration. The average extravascular concentration is calculated at a radial 
distance 0.2L from the blood vessel wall in SBC configuration (CSBC) as well as in the 2 BC 
configuration (C2BC). The percentage concentration deviation shown in Figure 6a is compared 
across different values of intercapillary separation. The intercapillary distances for different tissue 
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types in humans and small animals are recorded in Table 4. The blood capillary diameter, d, is 10 
𝜇𝑚 in accordance with the values reported in literature across humans, mice and rats (44, 46, 47). 
The L/d for tissue types shown in Table 4 lies between 5 and 21.5. So the analysis was performed 
for L/d=1, 5, 10, 25 and 125 for two solute molecular weights of 3.0 kDa and 10 kDa. For all the 
tests, the average extravascular concentration in the tissue volume surrounding the blood capillary 
is measured for each configuration. They are normalized by the maximum intravascular 
concentration in the blood capillary volume and the concentration-time history for each test is 
analyzed in the Results section. 
Non-Dimensionalization of the Convection-Diffusion-Decay process 
The final objective of this paper is to assimilate results of tests 1,2 and 3 to provide a unique non-
dimensional time at which tissue solute concentration is maximum. The solute concentration-time 
histories in specific radial locations of the tissue space are influenced by the drainage of the solutes 
in addition to the advection diffusion and decay processes as modelled by Eq 1. S is the surface 
area density of the micro vessels whose walls act as a sink in the tissue volume. The product of S 
and solute permeability (𝑃𝑑
𝑠) is the decay constant k. We define 𝜏 as the time when the inlet 
concentration drops to 36.7% of the maximum inlet concentration.  The first form of Eq 1 is non-
dimensionalized to find the time scales of the other transport mechanisms involved. Defining the 
following scaled variables * ; * ; * ; *
s
f
s f
c t x u
C t x U
Co L Uo
    , where Uo is the average velocity 
of fluid in tissue. Substituting these in Eq 1; we get the non-dimensional form as shown in Eq 2. 
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Eq 1 
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*
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f s s sF
C Uo D
R U C C kC
t L L




       
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     Eq 2      
The effect of 𝜏 on the solute accumulation in a tissue space is modified by the number of 
microvessels (n) present around it and the intercapillary separation (L/d) between them. The solute 
dependent timescales, obtained from Eq 2 are the modified input time scale (𝑛𝜏
𝐿
𝑑
), the diffusion 
timescale (
𝐿2
𝐷𝑡𝑖𝑠𝑠𝑢𝑒
) and the decay timescale (
1
𝑘
). These values for each solute in a SBC configuration 
are shown in Table 5. Since different timescales are dominant at different phases and radial 
locations of transport for differing solute types, a sum of all the solute dependent time scales is 
used to non-dimensionalize the time of solute accumulation and decay in tissue as shown in Eq 3. 
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tissue
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L L
n
d D k


 
 
 
Eq 3 
The extravascular concentration is rescaled to account for the variable solute molecular weight 
(Mw), solute density (𝜌), tissue porosity ∅ and varying intercapillary separation (L/d) as defined 
by Eq 4. 
 
 
 
Table 5 :Solute dependent timescales that influence concentration in tissue across time  
Solute 
(kDa) 
Input timescale  
( ) (s) 
Diffusion timescale 
(
2
tissue
L
D
 ) (s) 
Decay timescale 
(1/k) (s) 
0.1 284.5 25.4 125 
3 440.1 133.4 574.7 
10 604.8 241.7 1428.6 
40 1302 328.2 3030.3 
70 2319 778.9 3333.3 
Results  
Test 1: Effect of solute size in three configurations for fixed intercapillary separation 
The effect of solute size in the double blood capillary (2 BC) and the blood capillary -lymph vessel 
(BC_LC) configurations compared to the single capillary (SBC) is shown in Figure 4.  The tissue 
volume surrounding each capillary is equal. The concentration-time history essentially shows an 
initial accumulation period until the solute reaches its maximum concentration in the tissue space, 
then it is followed by a concentration decay. It is observed in the accumulation phase of the SBC 
configuration (Figure 4a inset) the 0.1 kDa, 3 kDa and 10 kDa solutes attain peak concentration 
* .
L
C
Mw d


  
Eq 4 
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with 41.3%, 40.3% and 30.7% of their maximum intravascular concentrations at 0.04, 0.07, and 
0.12 hour respectively whereas heavier solutes like 40 kDa and 70 kDa attain 26.9% and 30.5% of 
their maximum intravascular concentrations at 0.22 and 0.35 hour respectively.  
 
Figure 4:Extravascular concentration-time history of five solutes in a) the SBC configuration 
b) The 2 BC configuration and c) the BC_LC configuration. Solute concentration in the tissue 
space decreases with time and varies with solute size.  The inset in each subplot is a magnified 
view to show the concentration variation at earlier times for all three vessel configurations. 
Extravascular solute concentration reduces in a double blood capillary (2BC) configuration 
and decreases further in a lymph and blood capillary (BC_LC) configuration compared to 
single capillary (SBC) configuration.  
The time taken for 0.1 kDa, 3 kDa and 10 kDa solutes to reduce to 10% of their maximum 
intravascular concentrations are 0.43, 0.47 and 0.62 hour respectively whereas the same for the 
40kDa and 70kDa solutes are 1.57 and 3.25 hours respectively. The peak tissue concentration for 
0.1 kDa, 3 kDa, 10 kDa, 40 kDa and 70 kDa solutes decreases by 25%, 28%, 31%, 28% and 25% 
respectively in the 2 BC configuration (Figure 4b inset) and by 55%, 52%, 50%, 53% and 40% 
respectively in the BC_LC configuration (Figure 4c inset) with respect to the SBC configuration.  
In comparison to the SBC tissue peak concentration, the peak occurs at later times (Figure 4b) in 
2 BC configurations (3 kDa: 0.11 hour vs 0.07 hour; 10 kDa: 0.16 hour vs 0.12 hour; 40 kDa: 0.35 
hour vs 0.22 hour) and at earlier times (Figure 4c) in BC_LC configurations (3 kDa: 0.05 hour vs 
0.07 hour; 10 kDa: 0.07 hour vs 0.12 hour; 40 kDa: 0.16 hour vs 0.22 hour).  For the smallest 
solute 0.1 kDa, the concentration attains peak value later compared to its SBC counterpart (0.04 
hour) in both the 2 BC (0.07 hour) and BC_LC (0.05 hours) tissue spaces. On the contrary the 
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largest 70 kDa solute attains peak concentration earlier in both 2 BC (0.29 hour) and BC_LC (0.13 
hour) extravascular spaces compared to its SBC counterpart (0.35 hour). The 70 kDa solute, 
however, exhibits a faster onset of concentration decay both in the 2 BC and BC_LC configuration 
(SBC: 0.35 hour; 2 BC: 0.29 hour; BC_LC: 0.13 hour) while a delayed concentration decay is seen 
for the 0.1 kDa solute (SBC: 0.04 hour; 2 BC: 0.07 hour; BC_LC: 0.05 hour).       
Test 2: Effect of flow direction in microvessels 
The microvessel flows considered in test1 are in the same axial direction and are called co-current 
(CO) flows. They are compared with oppositely directed axial flows in the microvessels which are 
called counter current (CN) flows.  
 
Figure 5: Extravascular concentration-time history of five solutes for a) Co-current (CO) 
flow in microvessels in 2 BC configuration b) Counterflow (CN) in microvessels in 2 BC 
configuration c) Co-current (CO) flow in microvessels in BC_LC configuration and d) 
Counterflow (CN) in microvessels in BC_LC configuration Counterflow (CN) reduces the 
solute concentration in tissue space more than co-current flow (CO) in parallel capillary 
configuration. The effect is more pronounced for the 2BC configuration at earlier times. 
Figure 5 compares the CN flow with the CO flow for 2 BC configuration and BC_LC 
configuration respectively. In both configurations there is no difference between the two flow 
types during the solute accumulation phase in the tissue. As the tissue concentration decays, the 
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extravascular solute concentration is less in CN flow at later times compared to CO flow. The 
percentage reduction in concentration is more pronounced for larger (10 kDa: 0.5%; 40 kDa: 1.7%; 
70 kDa: 2.5 % ) solutes in 2 BC configuration (Figure 5a, Figure 5b). A similar observation is 
made in Figure 5a, Figure 5b for heavier (10 kDa: 0.12%; 40 kDa: 0.4%; 70 kDa: 0.5%) solutes 
but the difference is less in BC_LC configuration (Figure 5c, Figure 5d) compared to the 2 BC 
configuration. 
Test 3: Effect of intercapillary separation on transport of 3 kDa and 10 kDa solutes 
The intercapillary separation (L) was varied with respect to the vessel diameter (d) in the next set 
of tests for the 2 BC and BC_LC configurations. We calculated the average extravascular 
concentration at a radial distance 0.2L from the blood vessel wall in SBC configuration (CSBC) as 
well as in the 2 BC configuration (C2BC) where L is the intercapillary separation (Figure 6a). The 
percentage deviation between these two terms is plotted in Figure 6b across different values of 
non-dimensional intercapillary separation (L/d=1, 5, 10, 25, 125) for 3 kDa and 10 kDa solute. 
The dotted lines represent L/d values of 5 (yellow) and 21.5 (purple) which are the lower and upper 
limits of normalized intercapillary separation in breast tumors. L/d values above 21.5 are typically 
found in normal (non-diseased) tissues. 
      
Figure 6 : a) Schematic showing the setup and the calculation of % concentration deviation.  
b) Intercapillary separation (L/d) between 5 and 25 shows significant deviation of solute 
concentration in 2 BC and BC_LC configurations compared to SBC configuration for 3 kDa 
and 10 kDa solute sizes. 
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Double Blood Capillary (2 BC) embedded in tissue cylinder 
The 2 BC configuration shows minimum deviation (3 kDa: 1.5%; 10 kDa: 2.5%) from the SBC 
configuration for L/d=1 (Figure 6b). This is because the spacing between two blood capillary 
walls is so small that they effectively function as a single capillary with twice the original capillary 
diameter. So the solute accumulation almost the resembles that in a SBC configuration. The solute 
concentration deviation is substantial (9-33 %) for L/d=5-25 which is the range of interest as 
depicted in Table 4. The isolated capillary assumption will not hold true for extravascular solute 
accumulation in this regime. The deviation (3 kDa: 4.7%; 10 kDa: 8.5%) reduces for L/d=125 
because the large spacing between capillary walls minimizes the cumulative effect of the two blood 
vessels on the peak tissue concentration.  
Blood Capillary and Lymph Capillary (BC_LC) embedded in tissue cylinder 
The BC_LC configuration (Figure 6b) shows minimum deviation (3 kDa: 7.4%; 10 kDa: 7.3%) 
from the SBC configuration for L/d=125 due to the same reason as the 2 BC configuration. But 
with decreasing L/d the sink action of the lymph vessel become increasingly dominant resulting 
in 44%-55% deviation of the maximum solute concentration in tissue volume from that in the 
corresponding SBC configuration in the L/d regime of 1 to 25. 
Non-dimensional Time vs Peak Non-dimensional Concentration Analysis 
The results discussed in the previous cases have shown that the variation of solute size, microvessel 
arrangement, number of microvessels and intercapillary separation all contribute differently to the 
solute accumulation time vs solute decay time in the tissue space. Hence the non-dimensional 
extravascular solute concentration and non-dimensional time defined in Eq 4 and Eq 3 
respectively were calculated for all test cases to account for variations of these four parameters. 
The non-dimensional profiles for fixed L/d=1, 5, 10, 25, 125 were plotted in Figure 7a. All 
concentration peaks lie within T*=0.1 shown by the dotted black line. So, in Figure 7b the scaled 
concentration time-histories from T*=0 to T*=0.1 were analyzed. The peaks were extracted and 
plotted in Figure 7c. The red curves that correspond to the largest intercapillary distance (L/d=125) 
have  𝑇𝑝𝑒𝑎𝑘
∗  values which are one order of magnitude less than the average 𝑇𝑝𝑒𝑎𝑘
∗ . This is because 
for a large L, the second vessel does not contribute to the solute accumulation in the measurement 
location which is at a distance 0.2L from the first blood vessel. The concentration gradients across 
each capillary wall dynamically change the extravascular flux across the wall and for a large L the 
solute may get trapped within a certain distance of the capillary. The non-dimensional equations 
do not account for these and hence the deviation of 𝑇𝑝𝑒𝑎𝑘
∗  for L/d=125. It was concluded that the 
average non-dimensional time at which the peak concentration occurs in all configurations for all 
solutes is 𝑇𝑝𝑒𝑎𝑘
∗ =0.027 ±0.018 (Figure 7c).  
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Figure 7 : a) Non-dimensional concentration time history (T* vs C*) for all solute sizes in all 
tissue configurations with varying intercapillary separation  b) A magnified view of the non-
dimensional concentration time history to identify time occurrences of peak concentrations 
(C*) c) The peak concentration (C*) values are plotted separately to find an average non-
dimensional time of occurrence as 0.027 (𝑻𝒑𝒆𝒂𝒌
∗ )±0.018 (𝝈𝒔𝒕𝒅). 
Discussion  
We present a numerical model for breast tumor that can predict passive transport of nanoparticles 
across a multilayer barrier when the tissue architecture and nanoparticle properties are specified. 
The solute size (molecular weight and hydrodynamic diameter) influences its extravascular 
concentration dynamically across time. Smallest solutes are cleared faster from the tissue but they 
are also susceptible to getting trapped in the recirculation zone set up by countercurrent blood flow 
in adjacent vessels (54, 55). High clearance rates measured for solutes <10 kDa during in vivo 
measurements in tumors validate this observation. The therapeutic outcome of breast cancer drugs 
(Doxorubicin: 0.54 kDa; Cisplatin: 0.3 kDa) having similar molecular weight as the smallest solute 
investigated here can now be predicted for patient-specific tumor biopsies.  
Heavier nanoparticles (50-200 kDa) are preferred vehicles for the tumor location specific targeting 
and drug delivery(55, 56). According to the results, heavier solutes with hydrodynamic diameter 
(5-14 nm) take longer to attain maximum accumulation at a specific tissue location and are also 
removed slowly ((57, 58)). Presence of adjacent blood vessels with counter-current flow accelerate 
the clearance process owing to drainage from both ends of the tissue. Presence of a lymph vessel 
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reduces the magnitude of their peak concentration considerably owing to high permeability cross 
the lymph capillary wall. In various in vitro/in vivo studies the lymph wall is shown to allow 
unidirectional flow only (59-62) that facilitates better drainage. Easy removal of all sizes of drugs 
through the lymphatic system contributes to role of lymphatics in worse response(63). 
Blood vessels have been mostly modelled as non-porous structures permeable to solutes embedded 
in the flow (64, 65). To our knowledge, this is the first numerical model that account for endothelial 
porosity directly measured from dextran transport in an in vitro breast tumor model. Additionally, 
this work shows inclusion of multiple vessels in a tumor numerical model is necessary to 
accurately measure transport phenomena. The SBC assumption works only for tissues where 
capillaries are so close (L/d=1) that they act as a single vessel, e.g when nearby lymph vessels 
collapse (59, 60, 62, 63) during metastasis of some cancers or if they are so far apart (L/d=125) 
that the solute flux from one does not reach the other. 
The dextran transport investigated using a fabricated 3D microfluidic platform measured tissue 
porosity, endothelial porosity, nanoparticle permeability and nanoparticle diffusivity. Simulations 
driven by these parameters showed a close correspondence of numerical and experimental 
concentration-time histories. These parameters, when reported in literature, span over several 
orders of magnitude. The wide range can be attributed to the complex in vivo measurements whose 
intrusive nature would perturb the tissue microenvironment (17, 66). Thus, the ability to measure 
these parameters in vitro can be used to design future non-invasive transport investigation studies. 
Condensing all the effects of tissue architecture, solute and fluid transport properties, there exists 
a unique time 𝑇𝑝𝑒𝑎𝑘
∗  at which nanoparticle concentration in the tissue is maximum. Previous 
analytical solutions of a convective-dispersive solute transport equation with time-dependent inlet 
boundary condition (67, 68) have shown the dependence of time constant on the input timescale, 
convection timescale, decay timescale and the diffusion timescales but did not account for varying 
intercapillary separation. Later  Chapman et al. and other researchers (8, 12, 69) modeled transport 
in tumors characterized by intercapillary separation but did not account for the dynamic change of 
hydraulic permeability as a function of concentration gradients which in turn modulates the 
extravascular solute flux. The presented work, for the first time, analyzes the solute concentration 
in the tissue in the light of mixture theory equations for varying solute types, two parallel 
microvessels, differing flow directions in parallel vessels and tissue architecture and proposes a 
non-dimensional time at which solute concentration is maximum in the tissue. 
Since this approach non-dimensionalizes the intercapillary separation (L) with the vessel diameter 
(d), 𝑇𝑝𝑒𝑎𝑘
∗  can be predicted for tissues ranging over several scales and also for different disease 
stages (cancer vs normal). This prediction would aid in efficient endothelial targeting, triggering 
drug release and laser excitation for photothermal therapies (70-72). The 𝑇𝑝𝑒𝑎𝑘
∗  estimation can 
hugely impact the clinical landscape as it would customize treatment based on tumor specificity. 
Future studies with varying nanoparticle design, changing dosage, presence of magnetic targeting, 
receptor binding can all be implemented first to the mixture theory model whose predictions would 
increase the efficacy of the targeted drug delivery in patient specific tumors. 
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The major limitation associated with the study is simplification of the complex vascular network. 
The tortuosity and diameter variation of the microvessels were neglected. The extracellular matrix 
was considered stationary and not allowed to deform. A zero flux boundary condition was 
prescribed at each microvessel outlet which deviates from the physiological condition where a 
constant solute flux is drained to other organs like the liver from the microvessel outlets. 
Conclusion 
The study described in this paper focuses on quantification of solute transport across parallel blood 
vessels and initial lymph vessels in the light of mixture theory. Transport of nanoparticles to the 
targeted tumor volume is defined by the transport through microchannels, diffusion across 
endothelium and transport within the porous matrix, all of which were accounted for in the 
presented work. The results show that the solute size strongly influences its own rate of removal 
and rate of accumulation in the tissue. The flow physics in the extravascular space facilitate tissue 
drainage of nanoparticles depending on the solute size, the intercapillary separation and the 
microvessel arrangement in the tissue.  
A unique non-dimensional time 𝑇𝑝𝑒𝑎𝑘
∗   was reported for the first time. This is the time at which 
peak concentration of a nanoparticle occurs at any tissue location, irrespective of the solute size, 
the intercapillary separation and the microvessel flow direction. The knowledge of the nanoparticle 
introduction time, tissue mechanical properties and solute dependent properties will allow, in 
future, to design in vitro tissue models testing varying nanoparticle designs and concomitantly, 
predict for patient specific tumors, the appropriate time of drug release that can substantially 
improve drug efficacy. 
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Appendix A: Mixture theory model equations  
Fluid transport Equations 
The arterial pressure, Par, is specified at the inlet while the prescribed hydrostatic pressure 
difference, ∇𝑃 balances the viscous stresses to govern the fluid flow inside the capillaries 
according to    Eq. 1.   
2 0fP u                                                                                               Eq. 1  
  
The fluid flux, 𝑞𝑒, across the capillary wall (of radius Ro) as shown in Eq. 2  accounts for a) the 
hydrostatic pressure difference across the capillary wall due to the hydraulic conductivity,?̃?𝑝, b) a 
constant osmotic pressure gradient, 𝜎𝑝(?̃?𝑖
𝑝 − ?̃?𝑒
𝑝), due to protein molecules; and c) a variable 
osmotic pressure that depends on the concentration difference of the injected solute (of molecular 
weight 𝑀𝑤
𝑠  and density 𝜌𝑇
𝑠  ) in the intravascular (i) and the extravascular (e) space of a fibrous 
matrix with porosity ∅ .   
 Eq. 2 
The fluid transport in the extravascular space is influenced by a) the hydrostatic pressure difference 
in the tissue space, b) the hydraulic permeability of the tissue, 𝑘 and c) the solute concentration 
gradients, ∇𝑐𝑠 in the tissue space as depicted in                                                           Eq. 3. The 
retardation factor, 𝑅𝐹
𝒔 , is the ratio of the solute velocity and the fluid velocity in the tissue space. 
A constant pressure Po is applied to the tissue boundary. 
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                                                          Eq. 3 
Solute transport Equations 
The initial solute concentration, 𝐶𝑜, is used to prescribe the concentration at the inflow according 
to  Eq. 4. The concentration time history for the five solutes prescribed at the blood vessel inlet is 
shown in Figure 8. The concentration has been normalized by the peak intravascular concentration 
of each solute. 
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The advection-diffusion equation governs the solute transport inside the microvessels where 𝐷𝑠𝑓 
is the solute diffusion coefficient is shown below: 
. .( ) 0sf
c
u c D c
t

     

       Eq. 5 
 
Figure 8 : Concentration vs Time profile of five solutes at the blood vessel inlet.  
The solute particles carried by the fluid flux and those which permeate into the tissue space due to 
the concentration difference across the capillary wall constitute the solute flux (𝐽𝑠) across it. Eq. 6 
is a modified version of Starling’s law where 𝑃𝑑
𝑠 is the solute permeability coefficient and 𝜎𝑠 is 
the reflection coefficient. 
( | | ) (1 )s s s s ss r Ro r Ro ed i eJ P c c c q      
Eq. 6 
In the porous matrix of the extravascular space the solute undergoes both advection and diffusion 
as shown in the governing transport Eq. 7.  
. .( ) 0
s
s s s
f tissueF
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R u c D c
t
 

     

   Eq. 7 
The mixture theory equations are appropriate for this study since it shows the dependence of tissue 
mechanical properties like hydraulic conductivity on chemical gradients that is not captured by 
traditional transport models (13). 
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Difference of lymph vessel input parameters from that of blood vessel 
Solute concentration is zero at the lymph capillary inlet. The osmotic pressure gradient due to 
protein molecules is absent in the lymph vessel, (𝜎𝑝(?̃?𝑖
𝑝 − ?̃?𝑒
𝑝) = 0). The solute permeability 
coefficient, 𝑃𝑑
𝑠, across the lymph capillary wall is twice its value in blood capillary wall shown in 
Table 1 to account for the free permeability of lymph vessels to macromolecules. The fluid flux 
and the solute flux equations are modified to allow intravasation only. 
Appendix B: Fabrication of microfluidic platform 
Type I collagen was used as the extracellular matrix of the tumor with a single integrated 
endothelialized blood vessel. Excised tendons from rat tails were dissolved in a pH 2.0 HCl 
solution for 12h at 23˚C. The solution was centrifuged at 30000g for 45 minutes and sterilized 
using 10% (v/v) chloroform for 24h at 4˚C. The mold for the in vitro tumor microfluidic platform 
with the embedded single vessel was fabricated as described in previous work (73, 74). PDMS 
housing was fabricated using common soft-lithography methods. Polydimethylsiloxane (PDMS) 
and curing agent was mixed with 10:1 ratio and baked at 75˚C for 1 hour. Hardened PDMS housing 
and the glass cover slip was plasma treated for 18W for 30 seconds. Plasma treated surfaces were 
assembled to create a permanent bonding. The housing was treated with 1% (v/v) 
polyethyleneimine in dH2O for 10 min followed by 0.1% (v/v) glutaraldehyde in dH2O for 20 min 
and washed with dH2O twice. Collagen solution of 7 mg/ml was prepared by neutralizing stock 
solution with 1X DMEM, 10X DMEM, 1N NaOH, and mixing 1x106/ml MDA-MB-231 breast 
cancer cells uniformly in collagen which was then placed in the housing. A 22G (711µm) needle 
was inserted into the mold and after polymerization and the needle removal  a cylindrical vascular 
channel was created within the collagen.  2x106 TIME cells were injected into the vascular channel 
and exposed to flow preconditioning protocols for 3 days to form a confluent, aligned 
endothelialized vessel. As a result, in vitro platform shown in Figure 9 was fabricated. 
 
Figure 9: 3D vascularized in vitro microfluidic platform for experimental validation. a) CAD 
drawing of the platform. b) Confocal image of blood vessel with endothelial cells (red) surrounded 
by breast carcinoma cells (green). 
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Measuring mechanical properties from fabricated tissue platform 
Porosity Vasculature porosity was measured using confocal microscopy and imaging mKate 
labeled TIME cells. Scanning electron microscopy (Zeiss, Super40) was used to image 3 fibrous 
matrix samples under 15kx, 20kx, and 25kx magnifications at three vertical planes. Tissue porosity 
was measured by applying a Frangi filter on obtained images. 
Solute Permeability Obtained intensity profiles of 3 kDa and 70 kDa Dextran particles were used 
to calculate solute permeability coefficient as shown previously(75). 3kDa and 70kDa dextran 
particles were suspended in serum free endothelial basal medium at 10 µg/ml concentration and 
perfused in the vascular channel at 260 µL/min, which corresponds to 1 dyne/cm2 physiological 
shear stress for tumor vasculatures at every 3 minutes for 2 hours. The transport of these solutes 
was imaged using a confocal microscope (Leica SP8, 10X magnification). Normalized intensity 
profiles from this images as a function of time were used to compare with normalized 
concentration profiles from the equivalent numerical simulations. 
 
Solute Diffusivity Fluorescence recovery after photobleaching (FRAP) technique was used as 
described previously by Voigt et al. to measure the diffusion coefficient for a range of dextran 
molecular weights (4 kDa-150 kDa) for varying pH values, collagen concentrations and 
temperatures(76, 77). We selected diffusivity values of 3 kDa and 70 kDa for pH 7.6, collagen 
concentration 7mg/ml at 370C from the database of the mentioned study.  
Hydraulic tissue permeability Hydraulic permeability for  collagen at a concentration of 7 mg/ml as 
is used in fabrication of the platform were collected from the existing literature on vascularized in 
vitro experiments (40, 78, 79). 
 
 
 
